The power of data and market trends impacting pharmaceutical manufacturing and R&D facilities
Introduction
The global pharmaceutical industry is witnessing a surge in CEO confidence from US tax reforms, turbulent equity markets, and the strengthening global economy. The growth of the pharmaceutical industry is boosted by healthcare digitalization and democratization, creating an explosion in patient data, and the emergence of value-based reimbursement models. The convergence of biopharmaceuticals, drug delivery devices, and companion diagnostics—enabled by digital connectivity—is driving regulatory and commercial changes in many exciting ways for the industry.
Click here to Read More
